- Home
- AOD vs ORIC Comparison
AOD vs ORIC Comparison
Compare AOD & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AOD
- ORIC
- Stock Information
- Founded
- AOD 2006
- ORIC 2014
- Country
- AOD United Kingdom
- ORIC United States
- Employees
- AOD N/A
- ORIC N/A
- Industry
- AOD Investment Managers
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- AOD Finance
- ORIC Health Care
- Exchange
- AOD Nasdaq
- ORIC Nasdaq
- Market Cap
- AOD 988.9M
- ORIC 1.1B
- IPO Year
- AOD N/A
- ORIC 2020
- Fundamental
- Price
- AOD $9.56
- ORIC $12.96
- Analyst Decision
- AOD
- ORIC Strong Buy
- Analyst Count
- AOD 0
- ORIC 8
- Target Price
- AOD N/A
- ORIC $16.57
- AVG Volume (30 Days)
- AOD 423.5K
- ORIC 1.5M
- Earning Date
- AOD 01-01-0001
- ORIC 11-06-2025
- Dividend Yield
- AOD 12.95%
- ORIC N/A
- EPS Growth
- AOD 213.63
- ORIC N/A
- EPS
- AOD 1.93
- ORIC N/A
- Revenue
- AOD $72,962,082.00
- ORIC N/A
- Revenue This Year
- AOD N/A
- ORIC N/A
- Revenue Next Year
- AOD N/A
- ORIC N/A
- P/E Ratio
- AOD $4.44
- ORIC N/A
- Revenue Growth
- AOD N/A
- ORIC N/A
- 52 Week Low
- AOD $6.99
- ORIC $3.90
- 52 Week High
- AOD $9.14
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- AOD 51.64
- ORIC 53.61
- Support Level
- AOD $9.50
- ORIC $11.71
- Resistance Level
- AOD $9.71
- ORIC $13.80
- Average True Range (ATR)
- AOD 0.10
- ORIC 0.69
- MACD
- AOD -0.02
- ORIC -0.11
- Stochastic Oscillator
- AOD 54.76
- ORIC 50.63
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.